Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine

Abstract

Background: Methylmalonic acid (MMA) is a dicarboxylic acid whose concentration can be increased in blood and urine in patients with an inborn error of metabolism or vitamin B12 deficiency. We developed a method for the selective analysis of dicarboxylic acids that exploits the high specificity of tandem mass spectrometry (MS/MS) and the substantial difference in fragmentation patterns of the isomers methylmalonic (MMA) and succinic acid (SA). Methods: Dicarboxylic acids were extracted from samples with methyl-tert-butyl ether and derivatized with butanolic HCl to form dibutyl esters. The derivative was injected into the liquid chromatography (LC)-MS/MS system using TurboIonSpray™ (nebulizer-assisted electrospray) ionization and quantified by the multiple reaction monitoring mode of MS/MS. Results: The assay for MMA was linear up to 150 μmol/L. The total imprecision was ≤7.5% at both low and high concentrations. The limits of quantification and detection were 0.1 and 0.05 μmol/L, respectively. The degree of interference from SA could be predicted from the branching ratios of the major product ions. Conclusions: The method is specific for dicarboxylic acids. The LC-MS/MS analysis for MMA requires minimal chromatographic separation and takes <60 s per sample. The entire analysis, including sample preparation, for a batch of 100 specimens can be performed in <4h. © 2001 American Association for Clinical Chemistry.